Fluidigm and Genomenon to Offer Evidence-Based Genomic Panel Design Service

Joint offering enables acceleration of genomic panel design for translational and clinical disease research SOUTH SAN FRANCISCO, Calif., June 07, 2018 (GLOBE NEWSWIRE) — Fluidigm Corporation announced today that it has entered into a co-marketing agreement with Genomenon to offer evidence-based genomic panel design services for translational and clinical disease research. The rapidly expanding knowledge base of genes and... Read more

Bruker Announces Improved Solutions for Microbial Strain Typing, Hospital Hygiene and Infection Control, and Candida auris Testing at ASM 2018

– Improved IR Biotyper™ system for fast, routine and cost-effective strain typing for hospital infection control and earlier detection of outbreaks – FDA clearance for Candida auris identification with the MALDI Biotyper® to support better diagnostics and monitoring in critically ill patients ATLANTA, June 7, 2018 /PRNewswire/ — At the American Society for Microbiology (ASM) Microbe... Read more

Bio-Techne to Acquire Quad Technologies

 Download as PDF JUNE 07, 2018 MINNEAPOLIS, June 7, 2018 /PRNewswire/ — Bio-Techne Corporation (NASDAQ: TECH) announced today it has reached agreement to acquire all of the stock of QT Holdings Corporation d/b/a Quad Technologies. The transaction is expected to close in early July and to be financed through available cash on hand. “We are... Read more

QIAGEN welcomes new guidelines from American Academy of Pediatrics for detecting tuberculosis infection in children

Modern blood tests such as QuantiFERON-TB now recommended for patients ages 2 to 18 Germantown, Maryland, and Hilden, Germany, June 4, 2018 – QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that it welcomes new guidelines from the American Academy of Pediatrics (AAP) that recommend screening at-risk children as young as two years old... Read more

Waters Technologies for Food Safety, Food Authenticity and Biomedical Research at ASMS 2018

MILFORD, Mass.–(BUSINESS WIRE)– Waters (NYSE:WAT) is giving scientists attending ASMS 2018 a first look at new mass spectrometry technologies developed to serve the multi-faceted analytical requirements of food testing, university and biomedical research laboratories. The new products include a gas chromatography-mass spectrometry/mass spectrometry (GC-MS/MS) system for food safety analyses and a direct-analysis mass spectrometry system... Read more

Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center

Thermo Fisher Scientific Opens U.S. Precision Medicine Science Center Supports development of analytical workflows to generate precise molecular profiles of patients BOSTON and SAN DIEGO, June 4, 2018 /PRNewswire/ — BIO 2018 and ASMS 2018 — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today officially opened its U.S. Precision Medicine Science Center (PMSC)... Read more

SCIEX Announces Latest Innovations for Improving Healthcare and Well-being at ASMS

FRAMINGHAM, MASS – 04 June 2018 – SCIEX, a global leader in life science analytical technologies, has announced today that it will highlight a suite of recent innovations for streamlining biotherapeutics research and development, as well as its latest technologies for delivering accessible, high performance clinical diagnostics, at ASMS 2018. These developments have been optimized... Read more

BD, Helmer Scientific Collaborate to Introduce First Fully Integrated Refrigerated Automated Dispensing Solution

DENVER, June 4, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Helmer Scientific, a leading provider of integrated solutions to safeguard temperature-sensitive medications, today announced a collaboration to introduce an industry-first, medical-grade refrigerated solution integrated with an automated dispensing system to provide clinicians secure, single line-item access... Read more

Roche presents new data across a range of blood cancers at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting

Basel, 03 June 2018 Roche presents new data across a range of blood cancers at the 2018 American Society of Clinical Oncology (ASCO) Annual Meeting Further data demonstrate polatuzumab vedotin’s clinical efficacy across a range of diffuse large B-cell lymphoma subgroups Additional results from the randomised phase III MURANO study support fixed-duration Venclexta/Venclyxto plus MabThera/Rituxan... Read more